 
MACGT SECRETARIAT |
 Petaling Jaya, 12 February 2025 - The National Pharmaceutical Regulatory Agency (NPRA) of the Ministry of Health Malaysia held the NPRA Regulatory Updates 2025 briefing session with industry stakeholders on 12 February 2025. The session was attended by nearly 90 representatives from 18 associations across various sectors, including pharmaceuticals, health supplements, traditional medicine, cosmetics, and veterinary products. This session served as a vital platform for NPRA to share key regulatory updates, achievements, and ongoing initiatives from 2024, as well as its plans for 2025. It also fostered communication and collaboration between NPRA and industry associations, providing an opportunity for open discussions, direct engagement, and exchange of insights on regulatory matters. MACGT is honored and pleased to have participated in this important session. We look forward to collaborating with regulatory authorities and industry stakeholders to advance the development of Cell and Gene Therapy in Malaysia. Our goal is to elevate this field to the next level?gaining global recognition and achieving success in innovation and patient care.  |
|
|
